Annual Revenue
$45.56 M
+$31.47 M+223.37%
December 31, 2024
Summary
- As of March 10, 2025, NAMS annual revenue is $45.56 million, with the most recent change of +$31.47 million (+223.37%) on December 31, 2024.
- NAMS annual revenue is now -55.63% below its all-time high of $102.69 million, reached on December 31, 2022.
Performance
NAMS Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Revenue
$12.77 M
-$16.34 M-56.13%
December 31, 2024
Summary
- As of March 10, 2025, NAMS quarterly revenue is $12.77 million, with the most recent change of -$16.34 million (-56.13%) on December 31, 2024.
- Over the past year, NAMS quarterly revenue has dropped by -$16.34 million (-56.13%).
- NAMS quarterly revenue is now -56.13% below its all-time high of $29.11 million, reached on September 30, 2024.
Performance
NAMS Quarterly Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
TTM Revenue
$45.56 M
+$11.97 M+35.63%
December 31, 2024
Summary
- As of March 10, 2025, NAMS TTM revenue is $45.56 million, with the most recent change of +$11.97 million (+35.63%) on December 31, 2024.
- Over the past year, NAMS TTM revenue has increased by +$11.97 million (+35.63%).
- NAMS TTM revenue is now at all-time high.
Performance
NAMS TTM Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
NAMS Revenue Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +223.4% | -56.1% | +35.6% |
| 3 y3 years | - | -56.1% | +35.6% |
| 5 y5 years | - | -56.1% | +35.6% |
NAMS Revenue Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -55.6% | +223.4% | -56.1% | +1490.5% | at high | +564.0% |
| 5 y | 5-year | -55.6% | +223.4% | -56.1% | +1490.5% | at high | +564.0% |
| alltime | all time | -55.6% | +223.4% | -56.1% | +1490.5% | at high | +564.0% |
NewAmsterdam Pharma Company NV Revenue History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | $45.56 M(+223.4%) | $12.77 M(-56.1%) | $45.56 M(+35.6%) |
| Sep 2024 | - | $29.11 M(+1177.4%) | $33.59 M(+352.5%) |
| Jun 2024 | - | $2.28 M(+62.7%) | $7.42 M(+8.2%) |
| Mar 2024 | - | $1.40 M(+74.5%) | $6.86 M(-51.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2023 | $14.09 M(-86.3%) | $803.00 K(-72.7%) | $14.09 M(+6.0%) |
| Sep 2023 | - | $2.94 M(+71.3%) | $13.29 M(+28.4%) |
| Jun 2023 | - | $1.72 M(-80.1%) | $10.35 M(+19.9%) |
| Mar 2023 | - | $8.63 M | $8.63 M |
| Dec 2022 | $102.69 M | - | - |
FAQ
- What is NewAmsterdam Pharma Company NV annual revenue?
- What is the all time high annual revenue for NewAmsterdam Pharma Company NV?
- What is NewAmsterdam Pharma Company NV annual revenue year-on-year change?
- What is NewAmsterdam Pharma Company NV quarterly revenue?
- What is the all time high quarterly revenue for NewAmsterdam Pharma Company NV?
- What is NewAmsterdam Pharma Company NV quarterly revenue year-on-year change?
- What is NewAmsterdam Pharma Company NV TTM revenue?
- What is the all time high TTM revenue for NewAmsterdam Pharma Company NV?
- What is NewAmsterdam Pharma Company NV TTM revenue year-on-year change?
What is NewAmsterdam Pharma Company NV annual revenue?
The current annual revenue of NAMS is $45.56 M
What is the all time high annual revenue for NewAmsterdam Pharma Company NV?
NewAmsterdam Pharma Company NV all-time high annual revenue is $102.69 M
What is NewAmsterdam Pharma Company NV annual revenue year-on-year change?
Over the past year, NAMS annual revenue has changed by +$31.47 M (+223.37%)
What is NewAmsterdam Pharma Company NV quarterly revenue?
The current quarterly revenue of NAMS is $12.77 M
What is the all time high quarterly revenue for NewAmsterdam Pharma Company NV?
NewAmsterdam Pharma Company NV all-time high quarterly revenue is $29.11 M
What is NewAmsterdam Pharma Company NV quarterly revenue year-on-year change?
Over the past year, NAMS quarterly revenue has changed by -$16.34 M (-56.13%)
What is NewAmsterdam Pharma Company NV TTM revenue?
The current TTM revenue of NAMS is $45.56 M
What is the all time high TTM revenue for NewAmsterdam Pharma Company NV?
NewAmsterdam Pharma Company NV all-time high TTM revenue is $45.56 M
What is NewAmsterdam Pharma Company NV TTM revenue year-on-year change?
Over the past year, NAMS TTM revenue has changed by +$11.97 M (+35.63%)